Investigators reported 1-year disease-free survival results from patients with BCG-unresponsive papillary disease-only high-risk NMIBC in the phase 2b SunRISe-1 trial.

Actelis technology selected to support a major carrier’s multi-state customer base to modernize legacy T1 and TDM networks in the United States. Recent U.S. government FCC propo ...

We look back on T1’s top moments of the year, from qualifying for Worlds at the last moment, to lifting the Summoner's Cup for a record sixth time and putting on a show at Red Bull League of Its Own.

T1 will battle Team Liquid at the 2025 Kespa Cup finals, but does the reigning world champion have an overwhelming ...